BCHE and Sepsis: Previous researchers have reported that in animal models of sepsis, treatment with centrally acting cholinesterase inhibitors, including physostigmine, significantly reduced mortality, offered direct stimulation of the CAP, significantly decreased the binding activity of nuclear factor–kappa B, and reduced the concentration of tumor necrosis factor–α, interleukin-1β, and interleukin-6.